Top
Scientific Program

 

Plenary Lecture
| Nov. 30 | Dec. 1 | Dec. 2 | Dec. 3 |

Sunday, November 30, 2008, 09:20-10:00

PL 1 - How bacteria resist antibiotics: a primary form of intelligence?
Jean-Claude Pechère (Switzerland)

PL 2 - Clinical role of HBV genotypes  
Jia-Horng Kao (Taiwan)

PL 3 - Avian Influenza  
J.S. Malik Peiris (Hong Kong)

PL 4 - Genomic evolution of Resistance in Staphylococcus aureus 
Keiichi Hiramatsu (Japan)

Sunday, November 30, 2008, 14:20-15:00

PL 5 - Trend in New Agents Development
Morimasa Yagisawa (Japan)

PL 6 - Antibiotic Restrictions and Controlling Resistance: Lessons from the Pneumococcus
Donald E. Low (Canada)

PL 7 - Antibiotic leftovers in the outpatient setting
Giuseppe Cornaglia (Italy)

PL 8 - Circumcision and HIV Infection
John N. Krieger (USA)

Monday, December 1, 2008, 09:20-10:00

PL 9 - Controversies in the Management of CAP
Lionel A. Mandell (Canada)

PL 10 - Probiotics
Sherwood L. Gorbach (USA)

PL 11 - The potential for virulence inhibitors to prevent or ameliorate infectious diseases
Calvin M. Kunin (USA)

PL 12 - Treatment of CA-MRSA infection
Robert C. Moellering, Jr.(USA)

Monday, December 1, 2008, 14:20-15:00

PL 13 - Prenyltransferases as targets for antibiotic drug discovery
Andrew H.-J. Wang (Taiwan)

PL 14 - The Challenge of Quinolone Resistance
David C. Hooper  (USA)

PL 15 - Antimicrobial susceptibility testing: how to establish breakpoints?
Janet F. Hindler (USA)

PL16 - Pharmacokinetic and pharmacodynamic profiles of antibiotics in critically ill patients with sepsis
Teresita Mazzei (Italy)

Tuesday, December 2, 2008, 09:20-10:00

PL 17 - Strategy of antimicrobial resistance control
Raymond Wai-Hung Yung (Hong Kong)

PL 18 – Current Understanding of Kawasaki disease
Li-Min Huang (Taiwan)

PL 19 - CA-MRSA in Asia: an emerging threat to public health
Jae-Hoon Song (Korea)

PL 20 - Recent advances in therapy of sepsis
Chong-Jen Yu (Taiwan)

Tuesday, December 2, 2008, 14:20-15:00

PL21 - MDR, XDR, and PDR Gram-negative bacterial infections: a global threat
Matthew E. Falagas (Greece)

PL 22 - Living with extended-spectrum beta-lactamases 
David D. Livermore (UK)

PL 23 - Infectious burden and coronary artery disease 
Juey-Jen Hwang (Taiwan)

PL 24 - Glycopeptides, A History?
Donald P. Levine (USA)

Wednesday, December 3, 2008, 09:20-10:00

PL 25 - Source control and antibiotics in intra-abdominal infections
Joseph S. Solomkin (USA)

PL 26 - Fungal infections in the febrile neutropenic - can we do better?
Tan Ban Hock (Singapore)

PL 27 - Streptococcus suis, an emerging pathogen
Constance Schultsz (Vietnam)

top return to top